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Editorial
Candida burn wound sepsis: The ‘‘holy trinity” of management
 
 
 
 
Over the past few decades, survival following severe burn injury
has been substantially improved with fatal outcome nearly exclu-
sively observed among the elderly, patient with extreme (>85%)
total burnt surface area or patients suffering from inhalation injury
necessitating mechanical ventilation (Ryan et al., 1998; Brusselaers
et al., 2005; Belgian Outcome in Burn Injury Study Group, 2009).
 
 
The more severely burned cases are especially at risk of additional
 
 
complications, adding substantial morbidity.
Nosocomial infection frequently complicates the course of a
patient with burn injuries. These patients are at high-risk for infec-
 
 
tious complications for multiple reasons. The burned skin loses its
function as natural barrier against microbial species; the inﬂam-
matory storm provoked by the injury may take days or even weeks,
resulting in a down-regulated immune system; the critical illness
requires prolonged use of invasive devices such as intravascular
 
 
and urinary catheters and endotracheal tubes allowing mechanical
ventilation. Most frequently observed infections in burned patients
include ventilator-associated pneumonia (especially in case of
associated inhalation injury), bloodstream infection and catheter-
 
 
associated urinary tract infection (Brusselaers et al., 2010a, 2012;
 Patel et al., 2012; Norbury et al., 2016).
 
 
Conversely, burn wound sepsis has become relatively rare due
to innovations in surgery and optimisation of topical wound care
 
 
( ). BurnedDemling, 2008; Brusselaers et al., 2010b; Zuo et al., 2017
patients are often cared for in protective isolation to prevent them
from being colonised or infected with hospital-associated bacteria
such as Pseudomonas aeruginosa or methicillin-resistant Staphylo-
 
 
 
 
coccus aureus, two important pathogens often associated with out-
breaks in burn units (Douglas et al., 2001; Blot et al., 2003; Safdar
et al., 2006; Pednekar et al., 2010; Baier et al., 2017; Raes et al.,
 
 
2017). Furthermore, Candida infections, which are assumed to
 
 
 
 
originate from critically ill patients’ own gut mucosa or skin (Blot
 
 
and Vandewoude, 2004), may pose an additional infectious com-
plication. Therefore, protective isolation of burn victims is not
likely to favourably alter the risk of such infections.
In this issue of , Fan et al.Intensive & Critical Care Nursing
describe a rare case series of severely burned patients whose
course was complicated by Candida tropicalis burn wound sepsis
 
 
 
 
( ). The observation of a series of ﬁve cases urgesFan et al., 2018
 
 
 
 
clinicians to appreciate the risk for this infection. Albeit that it is
 
 
an opportunistic pathogen, and for that reason may favour severely
burned patients, Candida isolation from wounds generally repre-
sents colonisation rather than deep tissue invasion. Even a small
 
 
increase in the rate of wound sepsis should alert clinicians to con-
sider potential sources of this problem.
There are some interesting features in this case series that
weeks). Invasive candidiasis generally occurs in critically ill
patients after a prolonged course that resulted in a strongly debil-
 
 
itated physical condition, a typical feature of opportunistic patho-
 
 
gens. Second, the Candida sepsis was caused by the same species.
Little is known about speciﬁc risk factors for C. tropicalis, with
 
 
the exception that non-albicans Candida species are more often
isolated from patients who were previously exposed to ﬂuconazole
 
 
 
 
( ). Yet, none of the patients received antifun-Blot et al., 2001, 2006
gal prophylaxis before onset of the Candida sepsis. Third, all
 
 
patients underwent surgical interventions before onset of Candida
sepsis. Taking together these three observations (same Candida
 
 
 
 
species, early in the course and post-surgery) might raise a suspi-
 
 
cion of a common source of infection. This might be a contami-
nated piece of surgical equipment or a package of contaminated
dressings ( ). It should beBryce et al., 1996; Dancer et al., 2012
noted that the investigators did not support their study with
DNA ﬁngerprinting to assess the clonality of C. tropicalis as the
aetiological pathogen for the sepsis series. In terms of route-cause
analysis this would have been highly interesting. What argues
 
 
against a common source of infection is the relative wide time-
frame in which the cases are observed (2012–2014). This might
also be the reason why in-depth microbiological investigation
was not performed.
 
 
A ﬁnal remark on the series is that all patients, as per protocol,
received antimicrobial prophylaxis with meropenem. Due to their
broad antimicrobial spectrum, carbapenems are preferred for
empiric antibiotic therapy in patients with an overt risk proﬁle
for multidrug resistance involvement or for deﬁnite therapy in
the absence of an alternative ( ). The use ofVogelaers et al., 2010
this potent antimicrobial agent for prophylaxis is worrisome. First,
it does not match the international call for prudent use of antimi-
 
 
crobials and secondly, antimicrobial prophylaxis is not recom-
mended following burn injuries. Perhaps the speciﬁc situation of
the unit urged the authors to systematically use meropenem,
 
 
 
 
but no information on local microbial ecology was provided. Last
 
 
but not least, excessive use of broad-spectrum antibiotic therapy
is a signiﬁcant and well-recognised risk factor for invasive
candidiasis.
 
 
What is most important to keep in mind as the key message is
the ‘‘holy trinity” of fungal infection treatment and management,
 
 
which consists of (1) timely recognition of the potential fungal
infection, (2) early and appropriate administration of antifungal
treatment according to guidelines and local susceptibility patterns
and, (3) aggressive and extensive debridement of the infected tis-
 
 
sue (Spebar and Lindberg, 1979; Spebar et al., 1982; Pruitt et al.,
 1998; Norbury et al., 2016). All of them are such integral parts of
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There are some interesting features in this case series that
 
 
require clinician’s attention. First, most cases developed their Can-
dida wound sepsis early in the post-burn course (within two
 1998; Norbury et al., 2016). All of them are such integral parts of
the ‘best practice’ management, that dereliction of any, greatly
jeopardizes successful outcome.
https://doi.org/10.1016/j.iccn.2018.02.001
0964-3397/ 2018 Elsevier Ltd. All rights reserved.Ó
References
Baier, C., Ipaktchi, R., Ebadi, E., Limbourg, A., Mett, T.R., Vogt, P.M., et al, 2017. A
multimodal infection control concept in a burn intensive care unit – lessons
learnt from a methicillin-resistant Staphylococcus aureus outbreak. J. Hosp.
Infect. 26 .
Belgian Outcome in Burn Injury Study Group, 2009. Development and validation of
a model for prediction of mortality in patients with acute burn injury. Br. J. Surg.
96 (1), 111–117. John Wiley & Sons .
Blot, S., Vandewoude, K., 2004. Management of invasive candidiasis in critically ill
 
 
patients. Drugs 64 (19), 2159–2175 .
 
 
Blot, S., Vandewoude, K., Hoste, E., Poelaert, J., Colardyn, F., 2001. Outcome in
 
 
critically ill patients with Candidal fungaemia: Candida albicans vs. Candida
glabrata. J. Hosp. Infect. 47 (4), 308–313 .
Blot, S., Vandewoude, K., Hoste, E., Colardyn, F., 2003. Reappraisal of attributable
mortality in critically ill patients with nosocomial bacteraemia involving
Pseudomonas aeruginosa. J. Hosp. Infect. 53 (1), 18–24 .
 
 
 
 
Blot, S., Janssens, R., Claeys, G., Hoste, E., Buyle, F., De Waele, J.J., et al, 2006. Effect of
ﬂuconazole consumption on long-term trends in Candidal ecology. J.
 
 
Antimicrob. Chemother. 58 (2), 474–477. Oxford University Press .
Brusselaers, N., Hoste, E.A.J., Monstrey, S., Colpaert, K.E., De Waele, J.J., Vandewoude,
K.H., et al, 2005. Outcome and changes over time in survival following severe
burns from 1985 to 2004. Intensive Care Med. 31 (12), 1648–1653 .
Brusselaers, N., Monstrey, S., Snoeij, T., Vandijck, D., Lizy, C., Hoste, E., et al, 2010a.
 
 
Morbidity and mortality of bloodstream infections in patients with severe burn
injury. Am. J. Crit. Care 19 (6), e81–e87. American Association of Critical Care
Nurses.
 
 
Brusselaers, N., Pirayesh, A., Hoeksema, H., Richters, C.D., Verbelen, J., Beele, H., et al,
2010b. Skin replacement in burn wounds. J. Trauma 68 (2), 490–501 .
Brusselaers, N., Logie, D., Vogelaers, D., Monstrey, S., Blot, S., 2012. Burns, inhalation
injury and ventilator-associated pneumonia: value of routine surveillance
 
 
cultures. Burns 38 (3), 364–370 .
 
 
 
 
Bryce, E.A., Walker, M., Scharf, S., Lim, A.T., Walsh, A., Sharp, N., et al, 1996. An
outbreak of cutaneous aspergillosis in a tertiary-care hospital. Infect. Control
Hosp. Epidemiol. 17 (3), 170–172 .
 
 
Dancer, S.J., Stewart, M., Coulombe, C., Gregori, A., Virdi, M., 2012. Surgical site
infections linked to contaminated surgical instruments. J. Hosp. Infect. 81 (4),
231–238 .
Demling, R.H., 2008. Burns: what are the pharmacological treatment options?
Expert. Opin. Pharmacother. 9 (11), 1895–1908 .
Douglas, M.W., Mulholland, K., Denyer, V., Gottlieb, T., 2001. Multi-drug resistant
Pseudomonas aeruginosa outbreak in a burns unit–an infection control study.
Burns 27 (2), 131–135 .
Fan, C., Tian, Q., Huang, G., Zhang, L., Wu, Q., Zhang, K., 2018. Candida tropicalis burn
 
 
wound sepsis: a series of histopathology-conﬁrmed cases. Intensive Crit. Care
Nurs.
Norbury, W., Herndon, D.N., Tanksley, J., Jeschke, M.G., Finnerty, C.C., 2016. Infection
in Burns. Surg. Infect. (Larchmt) 17 (2), 250–255. Mary Ann Liebert, Inc., 140
Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA .
Patel, B.M., Paratz, J.D., Mallet, A., Lipman, J., Rudd, M., Muller, M.J., et al, 2012.
 
 
Characteristics of bloodstream infections in burn patients: an 11-year
 
 
retrospective study. Burns 38 (5), 685–690 .
Pednekar, S.N., Dohe, V.B., Deshpande, S.M., Kamble, S.S., Bharadwaj, R.S., Shouche,
Y.S., 2010. An outbreak of Pseudomonas aeruginosa in a burn unit. Burns 36 (7),
e130–e131 .
Pruitt, B.A., McManus, A.T., Kim, S.H., Goodwin, C.W., 1998. Burn wound infections:
current status. World J. Surg. 22 (2), 135–145 .
Raes, K., Blot, K., Vogelaers, D., Labeau, S., Blot, S., 2017. Protective isolation
precautions for the prevention of nosocomial colonisation and infection in burn
patients: a systematic review and meta-analysis. Intensive Crit. Care Nurs. 42,
22–29 .
Ryan, C.M., Schoenfeld, D.A., Thorpe, W.P., Sheridan, R.L., Cassem, E.H., Tompkins, R.
 
 
G., 1998. Objective estimates of the probability of death from burn injuries. N.
Engl. J. Med. 338 (6), 362–366. Massachusetts Medical Society .
Safdar, N., Marx, J., Meyer, N.A., Maki, D.G., 2006. Effectiveness of preemptive barrier
precautions in controlling nosocomial colonization and infection by methicillin-
resistant Staphylococcus aureus in a burn unit. Am. J. Infect. Control. 34 (8),
476–483 .
Spebar, M.J., Lindberg, R.B., 1979. Fungal infection of the burn wound. Am. J. Surg.
138 (6), 879–882 .
Spebar, M.J., Walters, M.J., Pruitt, B.A., 1982. Improved survival with aggressive
surgical management of noncandidal fungal infections of the burn wound. J.
Trauma 22 (10), 867–868 .
Vogelaers, D., De Bels, D., Forêt, F., Cran, S., Gilbert, E., Schoonheydt, K., et al, 2010.
Patterns of antimicrobial therapy in severe nosocomial infections: empiric
 
 
choices, proportion of appropriate therapy, and adaptation rates–a multicentre,
 
 
observational survey in critically ill patients. Int. J. Antimicrob. Agents 35 (4),
375–381 .
 
 
 
 
Zuo, K.J., Medina, A., Tredget, E.E., 2017. Important developments in burn care. Plast.
Reconstr. Surg. 139 (1), 120e–138e .
Dimitrios K. Matthaiou
Department of Critical Care Medicine, Attikon University Hospital,
 
 
University of Athens, Medical School, Athens, Greece
Stijn Blot
⇑
Faculty of Medicine & Health Science, Ghent University, Ghent, Belgium
⇑ Address: Ghent University, Dept. Internal Medicine, Campus UZ
Gent, Corneel Heymanslaan 10, 9000 Ghent, Belgium.
E-mail address: stijn.blot@UGent.be
Despoina Koulenti
Burns, Trauma and Critical Care Research Centre, University of
Queensland Centre for Clinical Research, Faculty of Medicine,
 
 
The University of Queensland, Brisbane, Queensland, Australia
Available online xxxx
2 Editorial / Intensive & Critical Care Nursing xxx (2018) xxx–xxx
15/05/18 14(52Candida burn wound sepsis: The “holy trinity” of management
Pagina 3 van 3https://reader.elsevier.com/reader/sd/BECDAC7BD048E461961…3DEBA2F5786DE8D2F8064D2AEE8D80A40F7CBC1A0A4A3A150655C0E7
